KPIs & Operating Metrics(New)
Growth Metrics

Xylem (XYL) EBITDA Margin (2016 - 2026)

Xylem has reported EBITDA Margin over the past 17 years, most recently at 11.48% for Q1 2026.

  • For Q1 2026, EBITDA Margin rose 32.0% year-over-year to 11.48%; the TTM value through Mar 2026 reached 13.6%, up 160.0%, while the annual FY2025 figure was 13.54%, 175.0% up from the prior year.
  • EBITDA Margin for Q1 2026 was 11.48% at Xylem, down from 14.73% in the prior quarter.
  • Over five years, EBITDA Margin peaked at 14.73% in Q4 2025 and troughed at 6.91% in Q2 2023.
  • A 5-year average of 11.31% and a median of 11.48% in 2026 define the central range for EBITDA Margin.
  • Biggest five-year swings in EBITDA Margin: plummeted -379bps in 2023 and later soared 475bps in 2024.
  • Year by year, EBITDA Margin stood at 13.08% in 2022, then dropped by -24bps to 9.96% in 2023, then grew by 19bps to 11.84% in 2024, then increased by 24bps to 14.73% in 2025, then dropped by -22bps to 11.48% in 2026.
  • Business Quant data shows EBITDA Margin for XYL at 11.48% in Q1 2026, 14.73% in Q4 2025, and 14.73% in Q3 2025.